All In Biotech

Drug Trial Radar · NCT05494788

Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)

Impact of CardiolRxTM on Recurrent Pericarditis An Open Label Pilot Study (MAvERIC-Pilot Study)

Last checked: Nov 19, 2026Latest source record: Oct 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

27

Actual

Start

Jan 9, 2023

Primary completion

Jun 15, 2024

Study completion Sep 6, 2024

Sponsor

Lead sponsor
Cardiol Therapeutics Inc.Industry
Sponsor type
Industry
First posted
Aug 10, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Patients with recurrent pericarditis who are refractory or intolerant to current therapeutic management options or who require long-term administration of corticosteroids to control their disease are particularly challenging to manage. The pathogenesis of pericarditis involves the activation of the inflammasome. CardiolRxTM (a pure cannabidiol \[CBD\] solution) is known to have anti-inflammatory properties, including modulation of inflammasome signaling. This pilot study is to assess the tolerance and safety of CardiolRxTM during the resolution of pericarditis symptoms, assess improvement in objective measures of disease, and during the extension period, assess the feasibility of weaning concomitant background therapy including corticosteroids while taking CardiolRxTM.

Conditions

  • Recurrent Pericarditis

Interventions

  • CardiolRxDrug

    Oral solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 11-point NRS Pain ScoreTime frame: 8 weeks

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Pima Heart and Vascular Clinical Research

    Tucson, Arizona

  • MedStar Health Research Institute

    Washington D.C., District of Columbia

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Minneapolis Heart Institute Foundation

    Minneapolis, Minnesota

  • Mayo Clinic

    Rochester, Minnesota

  • Cleveland Clinic

    Cleveland, Ohio

  • University of Vermont Medical Center

    Burlington, Vermont

  • Virginia Commonwealth University Health

    Richmond, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.